As the leader of the Pharmacokinetics (PK) Core at the Ivy Brain Tumor Center, our laboratory is established to provide state-of-the-art analytical platform for services and a broad range of pharmacological and pharmaceutical expertise critical in conducting clinical research. The Ivy Center hosts the largest number of Phase 0 clinical trials for brain tumor patients in the world and the results obtained in the PK Core within each ongoing clinical trial, along with the data received from Pharmacodynamics (PD) Core, will enable physicians to directly implement the most efficient regimens for brain tumor treatment. Such an approach is distinctly different from conventional clinical trials and is based on personalized precision medicine, where each patient has the unique prospect of receiving individualized therapeutic, therapeutic dose and schedule based on the results received from PK/PD Cores.
Artak Tovmasyan, PhDPharmacokinetics Core Leader
Dr. Artak Tovmasyan received his PhD Degree in Pharmaceutical Sciences from the Yerevan State Medical University, Armenia. He then completed…